Psilocybin use initiates hyperconnectivity in the brain linked to ego-modifying effects

FHS
May 24, 2024
3:48 am

A new study shows that the use of psilocybin, a compound found in the widely known “magic mushrooms,” initiates a pattern of hyperconnectivity in the brain linked to the ego-modifying effects and feelings of oceanic boundlessness.

Alexion and Verge enter AI-powered drug discovery deal

Alexion and Verge Genomics will focus on detecting drug targets for rare neurodegenerative and neuromuscular ailments. Credit: Yurchanka Siarhei/Shutterstock.com. Alexion, AstraZeneca Rare Disease has entered

September 11, 2023

Make the Diagnosis: It’s a Painless Pink Nodule. How Bad Could It Be?

Presentation A 49-year-old woman visited her doctor concerned about a lesion that developed over her right toe within the last 4 weeks. It was painless

August 17, 2023

Genentech partners with cash-strapped Sangamo on epigenetic Alzheimer’s therapy

An experimental Alzheimer’s drug and its designer are getting a second chance.On Tuesday, Sangamo announced it had partnered with Genentech to develop an epigenetic …

August 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.